DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses

Vaccine

Volumn 16, Issue 4, 1998, Pages 417-425

  Bahloul, Chokri ^a   Jacob, Yves ^a   Tordo, Noël ^a   Perrin, Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cross reactivity; DNA; Immunology; Lyssavirus; Protection; Rabies; Vaccine

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RABIES; RABIES VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; LYSSAVIRUS; MICE; MICE, INBRED BALB C; VACCINES, DNA; VIRAL FUSION PROTEINS;

EID: 0032007830     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00204-1     Document Type: Article

References (53)

1. 1 WHO, Rapport sur la Santé dans le Monde 1995. WHO, Geneva, 1996, p. 1.
2. 2 Charlton, K. The pathogenesis of rabies and other lyssaviral infections: recent studies. In Lyssaviruses (Eds. Rupprecht C., Diezschold, B. and Koprowski, H.), Springer-Verlag, Berlin, 1994, p. 95.
3. 3 Bourhy, H., Kissi, B. and Tordo, N. Molecular diversity of the Lyssavirus genus. Virology 1993, 194, 70.
4. 4 Ban, E. New virus leaves questions hanging. Nature Med. 1997, 3, 5.
5. 5 Delagneau, J.F., Perrin, P. and Atanasiu, P. Structure of rabies virus: spacial relationships of the proteins G, M1, M2 and N. Ann. Virol. (Inst. Pasteur) 1981, 132E, 473.
6. 6 Cox, J.H. The structural proteins of rabies virus. Comp. Immunol. Microbiol. Infect. Dis. 1982, 5, 21.
7. 7 Wiktor, T.J., Gyorgy, E., Schlumberger, H.D., Sokol, F. and Koprowski, H. Antigenic properties of rabies virus components. J. Immunol. 1973, 110, 269.
8. 8 Perrin, P., Thibodeau, L. and Sureau, P. Rabies immunosomes (subunit vaccine) structure and immunogenicity. Pre- and post exposure protection studies. Vaccine 1985, 3, 325.
9. 9 Dietzschold, B., Wang, H. and Rupprecht, C. et al. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc. Natl. Acad. Sci. U.S.A. 1988, 84, 9165.
10. 10 Lodmell, D.L., Smith, J.S., Esposito, J.J. and Ewalt, L.C. Cross-protection of mice against a global spectrum of rabies virus variants. J. Virol. 1995, 69, 4957.
11. 11 Fekadu, M., Shaddock, J., Sanderlin, D. and Smith, J. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine 1988, 6, 533.
12. 12 Lafon, M., Bourhy, H. and Sureau, P. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine 1988, 6, 362.
13. 13 Tordo, N., Bourhy, H., Sather, S. and Ollo, R. Structure and expression in the baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. Virology 1993, 194, 59.
14. 14 Dietzschold, B., Gore, M. and Marchadier, G. et al. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 1990, 64, 3804.
15. 15 Tang, D.C., DeVit, M. and Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152.
16. 16 Pertmer, T.M., Eisenbraun, M.D., McCabe, D., Prayaga, S.K., Fuller, D.H. and Haynes, J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995, 13, 1427.
17. 17 Xiang, Z.Q., Spitalnik, S., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132.
18. 18 Xiang, Z.Q., Spitalnik, S.L., Cheng, J., Erikson, J., Wojczyk, B. and Ertl, H.C. Immune responses to nucleic acid vaccines to rabies virus. Virology 1995, 209, 569.
19. 19 Ulmer, J.B., Donnelly, J.J. and Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745.
20. 20 Davis, H.L., Schirmbeck, R., Reimann, J. and Whalen, R.G. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Human Gene Ther. 1995, 6, 1447.
21. 21 Liu, M., Hilleman, M. and Kurth, R. DNA Vaccines: A New Era in Vaccinology. Annals of the New York Academy of Sciences. New York, 1995, pp. 1-294
22. 22 Shiver, J.W., Perry, H.C., Davies, M.E., Freed, D.C. and Liu, M.A. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann. N.Y. Acad. Sci. 1995, 772, 198.
23. 23 Coney, L., Wang, B. and Ugen, K.E. et al. Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 1994, 12, 1545.
24. 24 Ertl, H.C., Verma, P., He, Z. and Xiang, Z.Q. Plasmid vectors as anti-viral vaccines. Ann. N.Y. Acad. Sci. 1995, 772, 77.
25. 25 Mebatsion, T., Schnell, M.J. and Conzelmann, K.K. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J. Virol. 1995, 69, 1444.
26. 26 Brondyk, W. The pCl-neo mammalian expression vector. Promega Notes 1995, 51, 10.
27. 27 Perrin, P., Portnoï, D. and Sureau, P. Etude de l'adsorption et de la péńétration du virus rabique: interactions avec les cellules BHK-21 et les membranes artificielles. Ann. Virol. (Inst. Pasteur) 1982, 133E, 403.
28. 28 Joffret, M.L., Zanetti, C., Morgeaux, S., Leclerc, C., Sureau, P. and Perrin, P. Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production. Biologicals 1991, 19, 113.
29. 29 Morgeaux, S., Joffret, M.-L., Leclerc, C., Sureau, P. and Perrin, P. Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigens. Res. Virol. 1989, 140, 193.
30. 30 Perrin, P. Laboratory Techniques in Rabies (Eds. Meslin, F.-X., Kaplan, M.M. and Koprowski, H.). WHO, Geneva, 1996, p. 433.
31. 31 Smith, J.S., Yager, P.A. and Baer, G.M. Laboratory Techniques in Rabies (Eds. Kaplan, M.M. and Koprowski, H.). WHO, Geneva, 1973, p. 354.
32. 32 Maniatis, T., Fritsch, E. and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, 1982, pp. 1-545.
33. 33 Benmansour, A., Leblois, H. and Coulon, P. et al. Antigenicity of rabies virus glycoprotein. J. Virol. 1991, 65, 4198.
34. 34 van der Heijden, R., Langedijk, J., Groen, J., UytdeHaag, F., Meloen, R. and Osterhaus, D. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. J. Gen. Virol. 1993, 74, 1539.
35. 35 Lafay, F., Benmansour, A., Chebli, K. and Flamand, A. Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. J. Gen. Virol. 1996, 77, 339.
36. 36 Perrin, P., Versmisse, P., Delagneau, J.F., Lucas, G., Rollin, P. and Sureau, P. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. J. Biol. Standard. 1986, 14, 95.
37. 37 Castignolles, N., Morgeaux, S., Gontier-Jallet, C., Samain, D., Betbeder, D. and Perrin, P. A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens. Vaccine 1996, 14, 1353.
38. 38 Lin, H., Gontier, C., Saron, M.-F. and Perrin, P. A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects. Arch. Virol. 1993, 131, 307.
39. 39 Major, M., Vitvitski, L. and Mink, M. et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 1995, 69, 5798.
40. 40 Mebatsion, T., Schnell, M.J., Cox, J.H., Finke, S. and Conzelmann, K.K. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl Acad. Sci. U.S.A. 1996, 93, 7310.
41. 41 Sedlik, C., Dériaud, E. and Leclerc, C. Lack of Th1 or Th2 polarization of CD4+ Tcell response induced by particulate antigen targeted to phagocytic cells. Int. Immunol. 1996, 9, 91.
42. 42 Finkelman, F., Holmes, J. and Katona, I. et al. Lymphokyne control of in vivo immunoglobulin isotype selection. A. Rev. Immunol. 1990, 8, 303.
43. 43 Pertmer, T.M., Roberts, T.R. and Haynes, J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 1996, 70, 6119.
44. 44 Hassett, D. and Whitton, L. DNA immunization. Trends Microbiol. 1996, 4, 307.
45. 45 Xiang, Z.Q., Knowles, B.B., McCarrick, J.W. and Ertl, H.C. Immune effector mechanisms required for protection to rabies virus. Virology 1995, 214, 398.
46. 46 Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O. and Tokunaga, T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 1992, 148, 4072.
47. 47 Tokunaga, T., Yano, O. and Kuramoto, E. et al. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate Natural Killer cells. Microbiol. Immunol. 1992, 36, 55.
48. 48 Angela, Y., Barna, M., Zhengbiao, B. and Reiss, C. Host immune response to vesicular stomatitis virue infection of the central nervous system in C57BL/6 mice. Viral Immunol. 1996, 9, 195.
49. 49 Welsh, R. et al. Lymphocyte-dependent 'natural' immunity to virus infections mediated by both natural killer cells and memory T cells. Sem. Virol. 1996, 7, 95.
50. 50 Wunderli, P., Shaddock, J., Schmid, D., Miller, T. and Baer, G. The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines. Vaccine 1991, 9, 638.
51. 51 Perrin, P., Tino De Franco, M. and Jallet, C. et al. The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Res. Virol. 1996, 147, 289.
52. 52 Schneider, L.G., Dietzschold, B., Dierks, R.E., Matthaeus, W., Enzmann, P.J. and Strohmaier, K. Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses. J. Virol. 1973, 11, 748.
53. 53 Badrane, H., Bahloul, C., Kissi, B., Bourhy, H. and Tordo, N. Genetic diversity of lyssaviruses: implications in vaccinology, pathology and phylogeny. Submitted